SecBot SecBot

ARXS

Arxis, Inc.
Nasdaq· CIK 0002093536
$52.64 −0.09 (−0.17%)
Oct 27 4:00 PM ET · prev $52.73
Market cap
$22.3B
Large cap
Consensus
Buy
88% Buy or better · 16 analysts
Median target
$62.50
+19% · range $59.00–72.00
Since first trade
+35.8%
from $38.75 · Apr 16
30 days
+8.7%
from $48.44
Range since listing
$34.05–59.99
−12% from high · low May 18
Avg volume 20D
1.08M
shares / day
Short interest
5.71M
≈1.3% of shares · −4.1%
Days to cover
5.0
at average volume
Insider net
+$5.6M
7 buyers · 0 sellers · 12 mo
New fund stakes
34
Q2 2026 13F · 0 exits
Filing reports
13
analyzed by SecBot
SecBot read MIXED 7 reports · 90 days
Balance 0 bearish · 0 bullish · 1 mixed · 6 neutral oldest → newest, height = score
Avg score ·High conf. 3/7
Strongest NEUTRAL Arxis, Inc.'s S-1 registration statement (File No. 333-299412) was declared effective by the SEC on October…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    7 insiders bought $5.6M. No open-market sales.

  • InstitutionsBULLISH

    Q2 2026: 34 added (34 new), 0 trimmed or exited. Largest new: Capital International Investors $166.3M, Capital Research Global Investors $165.9M.

  • AnalystsBULLISH

    14 of 16 rate it Buy or better. Every target is above the price.

  • Short sellersSTEADY

    Short interest −4.1% to 5.71M shares. 5.0 days to cover, ≈1.3% of shares.

  • TrendUPTREND

    2% above its 50-day average.

Who's buying

13F· Q2 2026
34
new positions
0
exits
$1.8B
in new stakes
FundMoveSharesValue
Capital International InvestorsNEW3,603,927$166.3M
Capital Research Global InvestorsNEW3,595,083$165.9M
PRICE T ROWE ASSOCIATES INC /MD/NEW3,105,360$143.3M
AMERIPRISE FINANCIAL INCNEW2,656,793$122.6M
BlackRock, Inc.NEW2,196,658$101.4M
VANGUARD CAPITAL MANAGEMENT LLCNEW1,862,985$86.0M
CITADEL ADVISORS LLCNEW1,608,151$74.2M
MASSACHUSETTS FINANCIAL SERVICES CO /MA/NEW1,536,450$72.8M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

16 analysts
Buy 88% rate it Buy or better
Strong Buy7Buy7Hold2Sell0Strong Sell0
12-month targets · 10 analysts

Price is below the lowest target. Median implies +19%.Targets as of Oct 28, 2026.

Recent actions
DateFirmActionRating
Oct 2, 2026RBC Capital
UPGRADE
UPGRADEOutperform
Aug 13, 2026Citigroup
MAINTAIN
MAINTAINBuy
Aug 4, 2026Wells Fargo
MAINTAIN
MAINTAINOverweight
Jul 31, 2026Citigroup
MAINTAIN
MAINTAINBuy
Jul 31, 2026RBC Capital
MAINTAIN
MAINTAINSector Perform
Jul 1, 2026Citigroup
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$5.6M
bought · 7 insiders
$0
sold · 0 insiders
DateInsiderTypeValue
Aug 19, 2026
Roth Jason Aaron
See Remarks
AWARD34,098 sh
Jun 29, 2026
Jankowski Ryan Anthony
Chief Accounting Officer
AWARD8,517 sh
Apr 17, 2026
ALLEN PATRICK E
Director
BUY$280.0K
Apr 17, 2026
Roth Jason Aaron
See Remarks
BUY$1.7M
Apr 17, 2026
ALLEN PATRICK E
Director
AWARD5,357 sh
Apr 17, 2026
Perhamus Kevin Scott
See Remarks
BUY$1.5M
Apr 17, 2026
Oetgen Stephen Duane
Director
AWARD5,357 sh
Apr 17, 2026
Oetgen Stephen Duane
Director
BUY$700.0K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 15, 2026
5,706,907
shares short
-4.1%
vs prior settlement
5.0
days to cover
≈1.3%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 28, 2026 Earnings calendar
🔒 Fresh data, subscribers only
Oct 23, 2026 SEC
Arxis, Inc.'s S-1 registration statement (File No. 333-299412) was declared effective by the SEC on October 22, 2026…
EFFECT — Impact 5/10
Oct 15, 2026 SEC
Arxis announced it will report its Q3 2026 results on October 28, 2026.
PRESS-RELEASE — Impact 1/10
Oct 13, 2026 SEC
Arxis, Inc. filed an S-1 registration statement to register 13,351,964 shares of Class A common stock for resale by…
S-1 — Impact 4/10
Aug 19, 2026 Insider
Roth Jason Aaron was granted 34,098 shares
See Remarks
Aug 18, 2026 Press
Arxis completed its previously announced acquisition of Omnetics Connector Corporation for ~$770M enterprise value…
Impact 6/10
Jun 30, 2026 Inst.
Capital International Investors — NEW
3,603,927 shares ($166.3M)
Jun 30, 2026 Inst.
Capital Research Global Investors — NEW
3,595,083 shares ($165.9M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 28, 2026
Earnings date
🔒 Fresh data, subscribers only
Oct 15, 2026
Earnings
Arxis Schedules Third Quarter 2026 Earnings Release and Webcast
BLOOMFIELD, Conn., Oct. 15, 2026 /PRNewswire/ -- Arxis, Inc. (NASDAQ: ARXS) today announced that it will release its financial results for the third…
Sep 15, 2026
Short interest
Short Interest: ARXS up 22% to 3.6M shares
Settlement 2026-09-15 | Days to cover: 5.24 | ≈0.85% of shares outstanding (est.)
Aug 31, 2026
Short interest
Short Interest: ARXS up 30% to 2.9M shares
Settlement 2026-08-31 | Days to cover: 7.04 | ≈0.70% of shares outstanding (est.)
Aug 18, 2026
M&A
Arxis Completes the Acquisition of Omnetics Connector Corporation
BLOOMFIELD, Conn., Aug. 18, 2026 /PRNewswire/ -- Arxis, Inc. (NASDAQ: ARXS) (the "Company" or "Arxis"), a publicly traded industrial compounder…

SecBot reports

13 filings · 1 press release · 4 bullish · 0 bearish · 9 neutral
All ARXS filing & press-release reports (14)